Vmbook Online ordering

Icons

**Company Information**

**Name:** Heptagon Fill, Inc.

**Stock Symbol:** HPTG

**Exchange:** Nasdaq

**Sector:** Healthcare

**Industry:** Medical Devices

**Business Overview**

Heptagon Fill is a medical device company that specializes in the design, development, and manufacturing of single-use, prefilled drug delivery systems. The company's products include:

* Prefilled syringes

* Prefilled vials

* Prefilled cartridges

* Autoinjectors

Heptagon Fill's products are used to deliver a wide range of drugs, including biologics, vaccines, and small molecules. The company's customers include pharmaceutical and biotechnology companies.

**Financial Performance**

**Revenue:** $104.5 million (2022)

**Net Income:** $11.7 million (2022)

**Earnings Per Share (EPS):** $0.34 (2022)

**Growth:**

* Revenue has grown at a compound annual growth rate (CAGR) of 20% over the past 5 years.

* Net income has grown at a CAGR of 25% over the past 5 years.

* EPS has grown at a CAGR of 28% over the past 5 years.

**Valuation:**

* Market capitalization: $542 million

* Price-to-earnings (P/E) ratio: 30

* Price-to-sales (P/S) ratio: 5

**Key Metrics:**

* Gross margin: 55%

* Operating margin: 15%

* Net margin: 11%

* Return on equity (ROE): 20%

* Return on assets (ROA): 10%

**Outlook:**

Heptagon Fill is well-positioned for continued growth in the future. The company's strong financial performance, growing customer base, and innovative product pipeline are all positive indicators. The company is expected to continue to grow its revenue and earnings in the coming years.